HomeCompareERVFF vs JNJ

ERVFF vs JNJ: Dividend Comparison 2026

ERVFF yields 7692.31% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ERVFF wins by $4177739098279589.00M in total portfolio value
10 years
ERVFF
ERVFF
● Live price
7692.31%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4177739098279589.00M
Annual income
$4,073,565,928,588,968,500,000.00
Full ERVFF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — ERVFF vs JNJ

📍 ERVFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodERVFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ERVFF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ERVFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ERVFF
Annual income on $10K today (after 15% tax)
$653,846.15/yr
After 10yr DRIP, annual income (after tax)
$3,462,531,039,300,623,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, ERVFF beats the other by $3,462,531,039,300,623,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ERVFF + JNJ for your $10,000?

ERVFF: 50%JNJ: 50%
100% JNJ50/50100% ERVFF
Portfolio after 10yr
$2088869549139794.50M
Annual income
$2,036,782,964,294,484,200,000.00/yr
Blended yield
97.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ERVFF
No analyst data
Altman Z
5.3
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ERVFF buys
0
JNJ buys
0
No recent congressional trades found for ERVFF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricERVFFJNJ
Forward yield7692.31%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$4177739098279589.00M$30.5K
Annual income after 10y$4,073,565,928,588,968,500,000.00$4,749.88
Total dividends collected$4170772265337663.00M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ERVFF vs JNJ ($10,000, DRIP)

YearERVFF PortfolioERVFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$779,931$769,230.77$10,594$274.49+$769.3KERVFF
2$56,904,315$56,069,789.30$11,294$360.69+$56.89MERVFF
3$3,884,151,673$3,823,264,055.84$12,133$476.91+$3884.14MERVFF
4$248,050,254,929$243,894,212,638.74$13,156$635.42+$248050.24MERVFF
5$14,822,056,221,428$14,556,642,448,653.80$14,432$854.61+$14822056.21MERVFF
6$828,776,618,419,079$812,917,018,262,150.50$16,056$1,162.76+$828776618.40MERVFF
7$43,367,472,132,823,630$42,480,681,151,115,220.00$18,175$1,604.53+$43367472132.81MERVFF
8$2,123,871,047,251,591,000$2,077,467,852,069,469,400.00$21,009$2,252.68+$2123871047251.57MERVFF
9$97,358,102,514,598,310,000$95,085,560,494,039,100,000.00$24,911$3,229.73+$97358102514598.28MERVFF
10$4,177,739,098,279,589,000,000$4,073,565,928,588,968,500,000.00$30,458$4,749.88+$4177739098279589.00MERVFF

ERVFF vs JNJ: Complete Analysis 2026

ERVFFStock

Erin Ventures Inc. is an emerging international junior mining and exploration company engaged in the acquisition, exploration, and development of precious metal properties. Erin Venture's strategy is to uncover and capitalize on unique development opportunities within different regions internationally. The Company's objective is to increase its mineral reserves by developing current properties and through the acquisition of additional mining projects. We are expanding exploration activities at both our Ceibo Chico gold property in Belize, and our Deep River gold project in North Carolina and expect to offset costs on both properties through recently established gold production.

Full ERVFF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ERVFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ERVFF vs SCHDERVFF vs JEPIERVFF vs OERVFF vs KOERVFF vs MAINERVFF vs ABBVERVFF vs MRKERVFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.